1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 1999 ----------------------- Oncor, Inc. -------------------------------------------------------------- (Exact Name of Registrant as Specified in its Charter) Maryland -------------------------------------------------------------- (State or Other Jurisdiction of Incorporation) 0-16177 52-1310084 - ---------------------------------- ----------------------------------------- (Commission File Number) (I.R.S. Employer Identification No.) 209 Perry Parkway, Gaithersburg, Maryland 20877 -------------------------------------------------------------- (Address of Principal Executive Offices) (Zip Code) (301) 963-3500 -------------------------------------------------------------- (Registrant's Telephone Number, Including Area Code) N.A. -------------------------------------------------------------- (Former Name or Former Address, if Changed Since Last Report) 2 Item 5. Other Events - ------- ------------ 1. Joseph Shaya has been elected Acting President and Chief Executive Officer. 2. See attached press release. 3 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Oncor, Inc. -------------------------------------------- (Registrant) By: /s/ Joseph R. Shaya ---------------------------------- Name: Joseph R. Shaya Title: Acting President and Chief Executive Officer Dated: March 3, 1999 4 PRESS RELEASE - ------------------------------------------------------------------------------- FOR FURTHER INFORMATION CONTACT: ONCOR, INC. - -------------------------------- Joseph R. Shaya 209 Perry Parkway Acting President and CEO Gaithersburg, MD 20877 (301) 963-3500 Fax (301) 330-3940 - ------------------------------------------------------------------------------- FOR IMMEDIATE RELEASE ONCOR, INC. FILES ORDER OF RELIEF IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE GAITHERSBURG, MARYLAND -- FEBRUARY 26, 1999 . . . ONCOR, INC. announced that the Company and its wholly-owned subsidiary, Codon Pharmaceuticals, Inc., filed voluntary petitions for relief under Chapter 11 of the United States Code today in the United States Bankruptcy Court for the District of Delaware. The Company intends to reorganize its financial affairs. Oncor and Codon, both based in Gaithersburg, Maryland, are engaged in the development of genetic testing systems for the detection and management of significant life-threatening cancers and the development of genetic therapies, including gene-repair compounds. # # #